Literature DB >> 31469557

Machine Learning Models for Accurate Prediction of Kinase Inhibitors with Different Binding Modes.

Filip Miljković1, Raquel Rodríguez-Pérez1,2, Jürgen Bajorath1.   

Abstract

Noncovalent inhibitors of protein kinases have different modes of action. They bind to the active or inactive form of kinases, compete with ATP, stabilize inactive kinase conformations, or act through allosteric sites. Accordingly, kinase inhibitors have been classified on the basis of different binding modes. For medicinal chemistry, it would be very useful to derive mechanistic hypotheses for newly discovered inhibitors. Therefore, we have applied different machine learning approaches to generate models for predicting different classes of kinase inhibitors including types I, I1/2, and II as well as allosteric inhibitors. These models were built on the basis of compounds with binding modes confirmed by X-ray crystallography and yielded unexpectedly accurate and stable predictions without the need for deep learning. The results indicate that the new machine learning models have considerable potential for practical applications. Therefore, our data sets and models are made freely available.

Entities:  

Mesh:

Substances:

Year:  2019        PMID: 31469557     DOI: 10.1021/acs.jmedchem.9b00867

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  9 in total

1.  Data structures for computational compound promiscuity analysis and exemplary applications to inhibitors of the human kinome.

Authors:  Filip Miljković; Jürgen Bajorath
Journal:  J Comput Aided Mol Des       Date:  2019-12-02       Impact factor: 3.686

2.  Exploring kinase family inhibitors and their moiety preferences using deep SHapley additive exPlanations.

Authors:  You-Wei Fan; Wan-Hsin Liu; Yun-Ti Chen; Yen-Chao Hsu; Nikhil Pathak; Yu-Wei Huang; Jinn-Moon Yang
Journal:  BMC Bioinformatics       Date:  2022-06-20       Impact factor: 3.307

3.  Assessing the information content of structural and protein-ligand interaction representations for the classification of kinase inhibitor binding modes via machine learning and active learning.

Authors:  Raquel Rodríguez-Pérez; Filip Miljković; Jürgen Bajorath
Journal:  J Cheminform       Date:  2020-05-24       Impact factor: 5.514

4.  Successive Statistical and Structure-Based Modeling to Identify Chemically Novel Kinase Inhibitors.

Authors:  Lindsey Burggraaff; Eelke B Lenselink; Willem Jespers; Jesper van Engelen; Brandon J Bongers; Marina Gorostiola González; Rongfang Liu; Holger H Hoos; Herman W T van Vlijmen; Adriaan P IJzerman; Gerard J P van Westen
Journal:  J Chem Inf Model       Date:  2020-05-12       Impact factor: 4.956

5.  Prediction of kinase inhibitors binding modes with machine learning and reduced descriptor sets.

Authors:  Ibrahim Abdelbaky; Hilal Tayara; Kil To Chong
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

6.  Interpretable Machine Learning Models for Molecular Design of Tyrosine Kinase Inhibitors Using Variational Autoencoders and Perturbation-Based Approach of Chemical Space Exploration.

Authors:  Keerthi Krishnan; Ryan Kassab; Steve Agajanian; Gennady Verkhivker
Journal:  Int J Mol Sci       Date:  2022-09-24       Impact factor: 6.208

7.  EGFRisopred: a machine learning-based classification model for identifying isoform-specific inhibitors against EGFR and HER2.

Authors:  Ravi Saini; Subhash Mohan Agarwal
Journal:  Mol Divers       Date:  2021-08-03       Impact factor: 2.943

8.  Bcr-Abl Allosteric Inhibitors: Where We Are and Where We Are Going to.

Authors:  Francesca Carofiglio; Daniela Trisciuzzi; Nicola Gambacorta; Francesco Leonetti; Angela Stefanachi; Orazio Nicolotti
Journal:  Molecules       Date:  2020-09-14       Impact factor: 4.411

9.  KLIFS: an overhaul after the first 5 years of supporting kinase research.

Authors:  Georgi K Kanev; Chris de Graaf; Bart A Westerman; Iwan J P de Esch; Albert J Kooistra
Journal:  Nucleic Acids Res       Date:  2021-01-08       Impact factor: 16.971

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.